首页> 外文学位 >Biotechnology for immune cell detection and evaluation - Devices specifically designed to capture, detect or to evaluate alterations in leukocyte structure and function.
【24h】

Biotechnology for immune cell detection and evaluation - Devices specifically designed to capture, detect or to evaluate alterations in leukocyte structure and function.

机译:用于免疫细胞检测和评估的生物技术-专门设计用于捕获,检测或评估白细胞结构和功能变化的设备。

获取原文
获取原文并翻译 | 示例

摘要

The advent of Nano-biotechnology has opened a whole new area of biological study that has allowed us to pattern, manipulate, separate, evaluate and detect biological structures and functions that were previously not possible. This dissertation will describe different types of micro-fabricated devices that were designed to quantify and/or evaluate the functional activities of cells of the immune system. The micro-fabricated devices were developed in collaboration with our colleagues at Princeton University as part of our Cellular Micro-dynamics Program of the Nanobiotechnology Center (NBTC) at Cornell University.;A micro-fluidic "bump array" was designed to either separate cells or biological components based on changes in "hydrodynamic" cell size or particulate size; thus enabling the device to separate white blood cells (leukocytes) and platelets. The distribution histograms generated with the micro-device were comparable to that of forward light scatter analysis obtained by conventional flow cytometry. Advantages of the chip separator include significantly lower blood volume requirements and reduced costs per assay performed. Using a fabricated in vitro capillary device, it was successfully demonstrated that leukocyte subsets show differential ability to roll, adhere, chemotax and diapedesis under flow conditions in a micro-fabricated device. Neutrophils from blood delivered into the device can be assessed across the above mentioned functions without further modifications typical of current in vitro methods. One exception is that lymphocytes require additional adhesive or surface substrate adhesion molecules in order to assess these same normal biological functions in the micro-fluidic device. A fabricated T-cell biosensor was able to capture, detect and quantify the number of CD4 + lymphocytes from a few micro-liters of blood. The design of this type of device provides support that microdevices can be used to develop new diagnostic platforms that can evaluate alterations in immunological cell structure and functions using single sample and lower volumes of blood. These devices were used in several experiments exploring the role of stress in altering an organism's susceptibility to environmental stressors.;It was demonstrated that stress alters blood and bone marrow (BM) leukocyte populations following Acute Cold Restraint Stress (ACRS). It was shown that mice undergo lymphopenia shortly after ACRS while simultaneously undergoing neutrophilia and that these alterations are differentially mediated through the beta-Adrenergic Receptor (beta-AR) pathway. This increase in blood neutrophils following ACRS is due to the activation/mobilization of BM neutrophils, which was mediated by the sympathetic nervous system through a beta1-AR mechanism. However, alterations in CD3+ T-Cell trafficking were mediated through beta2-AR, while CD19+ B-cell trafficking was modulated through a combination of beta1-AR and beta2-AR. It was postulated that early activation of neutrophils associated with stress may lead to BM neutrophil exhaustion, which could lead to decreased host resistance to Listeria monocytogenes (LM) following stress.;The merging of Micro-/Nano-technology with biology will allowed current and future researchers to manipulate, pattern and view biological structures and functions in a way not previously possible. These types of devices, which are currently being developed, will be the research tools, diagnostic assays, detection sensors and medical delivery systems of tomorrow. The limitation for Nanobiotechnological applications in science only relies on ones imagination.
机译:纳米生物技术的出现为生物学研究开辟了一个全新的领域,使我们能够进行模式,操纵,分离,评估和检测以前不可能的生物学结构和功能。本论文将描述设计用来量化和/或评估免疫系统细胞功能活动的不同类型的微型设备。这些微制造的设备是与普林斯顿大学的同事合作开发的,是康奈尔大学纳米生物技术中心(NBTC)的细胞微动力学计划的一部分。微流控“凸点阵列”旨在分离细胞或基于“水动力”细胞大小或颗粒大小变化的生物成分;从而使设备能够分离白细胞(白细胞)和血小板。微型设备生成的分布直方图与通过常规流式细胞仪获得的前向光散射分析相当。芯片分离器的优点包括显着降低了血液需求量,并降低了每次检测的成本。使用制造的体外毛细血管装置,成功地证明了在微型制造的装置中,白细胞亚群在流动条件下显示出不同的滚动,粘附,化学趋化和透血能力。可以跨上述功能评估来自输送到设备中的血液的中性粒细胞,而无需对当前体外方法进行典型的进一步修改。一个例外是淋巴细胞需要额外的粘附剂或表面基质粘附分子,以评估微流控设备中的这些相同的正常生物学功能。预制的T细胞生物传感器能够从几微升血液中捕获,检测和量化CD4 +淋巴细胞的数量。此类设备的设计为微型设备可用于开发新的诊断平台提供了支持,该平台可使用单个样本和少量血液评估免疫细胞结构和功能的变化。这些设备被用于几个实验中,探索压力在改变生物体对环境压力的敏感性中的作用。事实证明,压力会在急性冷约束压力(ACRS)后改变血液和骨髓(BM)白细胞的数量。结果表明,小鼠在ACRS后不久发生淋巴细胞减少,而同时发生中性粒细胞增多,并且这些改变是通过β-肾上腺素能受体(β-AR)途径介导的。 ACRS后血液中性粒细胞的增加是由于BM中性粒细胞的激活/动员,它是由交感神经系统通过β1-AR机制介导的。但是,CD3 + T细胞运输的改变是通过beta2-AR介导的,而CD19 + B细胞运输是通过beta1-AR和beta2-AR的组合来调节的。据推测,与压力相关的嗜中性粒细胞的早期活化可能导致BM中性粒细胞的耗尽,这可能导致宿主在压力后对单核细胞增生性李斯特菌(LM)的抵抗力下降。;微/纳米技术与生物学的融合将允许电流和未来的研究人员将以前所未有的方式操纵,模式化和查看生物结构和功能。目前正在开发的这些类型的设备将成为未来的研究工具,诊断测定,检测传感器和医疗传输系统。纳米生物技术在科学中的应用局限性仅在于想象力。

著录项

  • 作者

    Zieziulewicz, Thomas J.;

  • 作者单位

    State University of New York at Albany.;

  • 授予单位 State University of New York at Albany.;
  • 学科 Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 196 p.
  • 总页数 196
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号